EDAP TMS S.A. (NASDAQ: EDAP) Announces Collaboration with Telix on Prostate Cancer Technologies
Key Developments EDAP TMS S.A. (NASDAQ: EDAP) has declared a new strategic partnership with Telix Pharmaceuticals Limited to advance clinical research and physician education in prostate cancer treatment. This collaboration centers on combining EDAP’s Focal One Robotic HIFU system with Telix’s PSMA PET imaging products, aiming to enhance management options for patients. The companies have formalized their intent through a letter of intent to explore joint efforts in integrating robotic…
